{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ANDREW ROSS SORKIN", "person": [{"middlename": "Ross", "firstname": "Andrew", "lastname": "SORKIN", "rank": 1, "role": "reported", "organization": ""}]}, "abstract": "Andrew Ross Sorkin DealBook column faults Pershing Square Capital Management leader Bill Ackman for missing financial fraud occurring at Valeant Pharmaceuticals, which led to steep loss for investors in his hedge fund. ", "type_of_material": "News", "word_count": "859", "lead_paragraph": "The hedge fund manager, who made billions spotting financial fraud but missed any signs of chicanery at Valeant, is hoping to salvage his investment.", "pub_date": "2016-03-22T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Bill Ackman Bets Again on Valeant, Taking a Seat on the Board", "content_kicker": "DealBook", "print_headline": "Many Burned by Ackman\u2019s Bold Bet", "kicker": "DealBook Column"}, "snippet": "The hedge fund manager, who made billions spotting financial fraud but missed any signs of chicanery at Valeant, is hoping to salvage his investment.", "multimedia": [{"height": 126, "url": "images/2016/03/22/business/22db-sorkin-web1/22db-sorkin-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/03/22/business/22db-sorkin-web1/22db-sorkin-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 399, "url": "images/2016/03/22/business/22db-sorkin-web1/22db-sorkin-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "399", "xlarge": "images/2016/03/22/business/22db-sorkin-web1/22db-sorkin-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/03/22/business/22db-sorkin-web1/22db-sorkin-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/03/22/business/22db-sorkin-web1/22db-sorkin-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/03/22/business/dealbook/bill-ackman-bets-again-on-valeant-taking-a-seat-on-the-board.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Ackman, William A", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Pershing Square Capital Management", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Hedge Funds", "name": "subject"}], "blog": [], "_id": "56f098b438f0d82d2a6d5e23", "source": "The New York Times"}